Shares of Moderna slid 2.65% to $111.35 at 11:52 EST on Wednesday, following last session’s upward trend. NASDAQ Composite is jumping 0.37% to $12,897.33, following last session’s downward trend, This seems, up until now, a somewhat positive trend trading session today.
Moderna’s last close was $114.39, 60.31% below its 52-week high of $178.50.
News about Moderna today
Moderna in talks with south korea to provide about 40 mln doses of Covid-19 vaccine. According to today’s article on Business Insider, "Moderna Inc. (MRNA) confirmed Tuesday that it is engaged in discussions with the government of South Korea to potentially provide 40 million or more doses of the Moderna COVID-19 Vaccine."
Moderna, emergent biosolutions, osmotica: what to watch when the stock market opens today. According to today’s article on The Wall Street Journal, "- Moderna shares rose 3.5% premarket, building on yesterday’s gains. "
Moderna’s sales growth is 1841.7% for the current quarter and 19117.5% for the next. The company’s growth estimates for the present quarter is a negative 13.5% and positive 660% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s last day, last week, and last month’s average volatility was a positive 2.68%, a negative 4.01%, and a negative 0.48%, respectively.
Moderna’s last day, last week, and last month’s high and low average amplitude percentage was 8.77%, 10.97%, and 10.45%, respectively.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $111.35 at 11:52 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s worth is way under its 50-day moving average of $125.12 and way higher than its 200-day moving average of $83.25.
Previous days news about Moderna
Moderna to offer vaccine to workers, contractors and board. According to The Wall Street Journal on Tue Dec 29, "The Cambridge, Mass., company, which has about 1,200 employees, said the small quantities of vaccine needed for the program are separate from the millions of doses Moderna has committed to the U.S. government.", "Moderna Inc. said Tuesday it will offer its new Covid-19 vaccine to its own employees, contractors and board members in a move the company said would provide an additional layer of protection to workers involved in making and delivering the vaccine."